Giovanni Turtulici1 , Davide Orlandi2 , Angelo Corazza2 , Riccardo Sartoris2 , Lorenzo Egildo Derchi3 , Enzo Silvestri1 and Jung Hwan Baek4 , 1 Dipartimento di Radiologia e Ecografia Interventistica, Ospedale Evangelico Internazionale, Genova, Italy, 2 Scuola di Specializzazione in Radiodiagnostica, Universita degli Studi di Genova, Genova, Italy, 3 Dipartimento di Radiologia, Universita degli Studi di Genova, IRCCS AOU San martino IST, Genova, Italy and 4 Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Ultrasound in Medicine and Biology, 2014; 40(7): 1447-1452
The authors performed a retrospective hospital institutional review board approved study to validate the feasibility and outcome of using a virtual needle tracking system (VirtuTRAX, CIVCO Medical Solutions, Kalona, IA) combined with real-time imaging to perform ultrasound (US)-guided percutaneous radiofrequency ablations (RFA) of benign thryoid nodules. Ultrasound imaging during pre-procedure planning and ablation helps to identify delicate anatomy such as the laryngeal nerve and other vital structures located near the thyroid. The virtual needle tracking system provides added RF electrode visualization during the ablation when changes in the tissues cause artifacts that obscure visualization.
Two subject groups were created based on expected complexity of a single nodule treatment. Group A patients underwent in-plane ultrasound-guided radiofrequency ablation of a thyroid nodule located less than 5cm from the skin surface and had anatomy demonstrating obvious trachea-esophageal groove margins under ultrasound imaging. Group B patients underwent out-of-plane approach to access the deepest margin of the nodule. The selected nodule was deeper than 5cm with a poorly detected trachea-esophageal groove margin.
All patients underwent a single radiofrequency puncture. The overall mean volume reduction of the nodule was greater than 70% with no difference in reduction seen between Group A and Group B. At 6-month follow-up, the treated nodules did not show signs of re-growth that would require additional treatment. Patient satisfaction with the outcome of the procedure was 93%. One patient in Group A experienced a first-grade skin burn.
Ultrasound-guided radiofrequency ablation of a benign thyroid nodule performed using VirtuTRAX: